Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. (Q51189483)
Jump to navigation
Jump to search
scientific article published in November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. |
scientific article published in November 2013 |
Statements
1 reference
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. (English)
1 reference
1 reference
Janet Wittes
1 reference
Hans-Henrik Parving
1 reference
Robert D Toto
1 reference
Tadao Akizawa
1 reference
Paul Audhya
1 reference
George L Bakris
1 reference
Heidi Christ-Schmidt
1 reference
Angie Goldsberry
1 reference
Melissa Krauth
1 reference
Hiddo J Lambers Heerspink
1 reference
Colin J Meyer
1 reference
Nosratola D Vaziri
1 reference
Danielle Wrolstad
1 reference
Glenn M Chertow
1 reference
Peter Linde
1 reference
Christoph Wanner
1 reference
Dick de Zeeuw
1 reference
1 November 2013
1 reference
28
1 reference
2841-2850
1 reference
11
1 reference
Identifiers
1 reference